Katrin Thüne

The cellular prion protein and its derived fragments in human prion diseases and their role as potential biomarkers

I. Zerr, F. Llorens, M. Glatzel, 2019, Expert review of molecular diagnostics.

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias

I. Ferrer, I. Zerr, R. Sánchez-Valle, 2017, Molecular Neurodegeneration.

Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases

B. Mollenhauer, P. Liberski, D. Varges, 2017, Alzheimer's & Dementia.

Identification of new molecular alterations in fatal familial insomnia.

Christopher J. Silva, I. Ferrer, I. Zerr, 2016, Human molecular genetics.

MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives

I. Zerr, D. Dafou, T. Sklaviadis, 2018, Front. Aging Neurosci..

Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis

J. Díez, J. D. del Río, I. Zerr, 2018, PLoS pathogens.

Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays

H. Vanderstichele, I. Zerr, F. Llorens, 2020, Translational Neurodegeneration.

Altered Ca2+ homeostasis induces Calpain-Cathepsin axis activation in sporadic Creutzfeldt-Jakob disease

P. Liberski, I. Zerr, S. Bonn, 2017, Acta neuropathologica communications.